Haleon schedules Toronto Health House as Goldman keeps Buy for Haleon stock

Published on 10/20/2026 at 13:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Haleon schedules a Toronto health event for October 23, 2026. Haleon stock trades at EUR 4.53 on October 20, 2026 before its October 29 update.

Company events and analyst view

Haleon scheduled its Toronto Health House for October 23, 2026, following a survey of 1,528 Canadians.
First-half 2026 revenue reached GBP 5.60 billion, with organic growth of 2.60 percent.
Haleon stock trades at EUR 4.53 at 1:40 p.m. CEST at Lang & Schwarz on October 20, 2026.
Goldman Sachs reiterated its Buy rating with a GBp 460.00 target on October 7, 2026.

Architektur-Render eines Glasbürogebäudes mit begrüntem Vorplatz und Menschen — Haleon plc (ISIN GB00BMX86B70) repräsentiert ein globales Konsumgüterunternehmen mit modernen Bürostandorten für Gesundheitsprodukte, Illustration mit AI erstellt.

Haleon (ISIN GB00BMX86B70) is trading at EUR 4.53 at Lang & Schwarz on October 20, 2026 at 1:40 p.m. CEST. The company scheduled its Toronto Health House for October 23, 2026, while Business Insider reported the event on October 19, 2026.

Toronto event and 1,528-person survey

Haleon Canada will present brands including Advil, Centrum, Sensodyne, TUMS and Voltaren at the one-day event. The company said the accompanying survey covered 1,528 Canadian respondents, with 66 percent saying they felt confident selecting the right treatment or product, according to Business Insider.

Three dated Haleon developments

On July 30, 2026, first-half revenue reached GBP 5.602 billion, up 2.60 percent organically, according to DK Street Journal. On October 7, 2026, Goldman Sachs reiterated a Buy rating and set a GBp 460.00 price target, as reported by Business Insider. On October 19, 2026, Haleon announced the October 23 Health House date and the event details.

What comes next for Haleon?

The next dated company events are the Toronto Health House on October 23, 2026, and Haleon's third-quarter trading statement on October 29, 2026. Haleon's investor-relations page identifies the latter as an upcoming event and describes the group as a pure-play consumer health company with a medium-term organic revenue growth algorithm of 4 percent to 6 percent.

Stock price before the Q3 update

For investors, the key near-term test is whether the October 29 statement clarifies the pace of organic growth after the first-half result. Haleon's market capitalization stood at GBP 33.2 billion at the October 19, 2026 close on its London listing.

Haleon was trading at EUR 4.53 at Lang & Schwarz on October 20, 2026 at 1:40 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Haleon stock.